Rongshuang Luo, Zhongyuan Wang, Dali Luo, Yumei Qin, Chunshen Zhao, Di Yang, . . . Zhuyan Huang. (2021). Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors. Taylor & Francis Group.
Chicago Style (17th ed.) CitationRongshuang Luo, Zhongyuan Wang, Dali Luo, Yumei Qin, Chunshen Zhao, Di Yang, Tian Lu, Zhixu Zhou, and Zhuyan Huang. Design, Synthesis, and Biological Evaluation of Novel Triazoloquinazolinone Derivatives as SHP2 Protein Inhibitors. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationRongshuang Luo, et al. Design, Synthesis, and Biological Evaluation of Novel Triazoloquinazolinone Derivatives as SHP2 Protein Inhibitors. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.